SEC 13F Intelligence

Ellsworth Advisors, LLC / NBIX

Ellsworth Advisors, LLC’s Neurocrine Biosciences Inc Position

Does Ellsworth Advisors, LLC own Neurocrine Biosciences Inc (NBIX)? Yes39.6K shares worth $7M (+1.12% of its 13F portfolio) as of Q2 2026.

Position Value
$7M
Q2 2026
Shares
39.6K
% of Portfolio
+1.12%
Quarters Held
1
currently held

Position History NBIX

Reported value by quarter
Q2 ’26: $7MQ2 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202639.6K$7M+1.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ellsworth Advisors, LLC’s full portfolio or all institutional holders of NBIX.